Glutamine Plus L. Reuteri Prevents TKI Therapy-diarrhea in Patients With NSCLC

Clinical trial NCT05852990 · RECRUITING

Trial details

NCT number: NCT05852990
Sponsor: Instituto Nacional de Cancerologia de Mexico
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer With EGFR Mutation

Start date: 2022-03-01
Primary completion: 2026-12-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.